Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy

Nephrology

Volumn 18, Issue 9, 2013, Pages 585-591

  McKercher, Charlotte ^a   Sanderson, Kristy ^a   Jose, Matthew D ^a,b,c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c ROYAL HOBART HOSPITAL   (Australia)

Author keywords

chronic kidney disease (CKD); epidemiology; psychology psychiatry

Indexed keywords

ANXIETY DISORDER; ARTICLE; CHRONIC KIDNEY DISEASE; DEPRESSION; DISEASE COURSE; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

CHRONIC KIDNEY DISEASE (CKD); EPIDEMIOLOGY; PSYCHOLOGY/PSYCHIATRY;

ADAPTATION, PSYCHOLOGICAL; ANXIETY DISORDERS; COST OF ILLNESS; DEPRESSION; DISEASE PROGRESSION; HUMANS; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK FACTORS; SOCIAL SUPPORT;

EID: 84883273716     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12138     Document Type: Article

References (54)

1. Bruce M, Beech B, Sims M, et al. Social environmental stressors, psychological factors, and kidney disease. J. Invest. Med. 2009; 57: 583-589.
2. Martikainen P, Bartley M, Lahelma E,. Psychosocial determinants of health in social epidemiology. Int. J. Epidemiol. 2002; 31: 1091-1093.
3. Katon W, Lin E, Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N. Engl. J. Med. 2010; 363: 2611-2620.
4. Sareen J, Jacobi F, Cox B, Belik S, Clara I, Stein M,. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch. Intern. Med. 2006; 166: 2109-2116.
5. Grace BS, Clayton P, McDonald SP,. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrology 2012; 17: 76-84.
6. Jose MD, Otahal P, Kirkland G, Blizzard L,. Chronic kidney disease in Tasmania. Nephrology 2009; 14: 743-749.
7. Chan HW, Clayton PA, McDonald SP, Agar JW, Jose MD,. Risk factors for dialysis withdrawal: An analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. Clin. J. Am. Soc. Nephrol. 2012; 7: 775-781.
8. Stein MB, Cox BJ, Afifi TO, Belik S, Sareen J,. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol. Med. 2006; 36: 587-596.
9. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-3105.
10. Thong MS, Kaptein AA, Krediet RT, Boeschoten EW, Dekker FW,. Social support predicts survival in dialysis patients. Nephrol. Dial. Transpl. 2007; 22: 845-850.
11. Christensen AJ, Wiebe JS, Smith TW, Turner CW,. Predictors of survival among hemodialysis patients: Effect of perceived family support. Health Psychol. 1994; 13: 521-525.
12. Fischer MJ, Kimmel PL, Greene T, et al. Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int. 2010; 77: 1010-1019.
13. Ver Halen N, Cukor D, Constantiner M, Kimmel P,. Depression and mortality in end-stage renal disease. Curr. Psychiatry Rep. 2012; 14: 36-44.
14. Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2007; 2: 484-490.
15. Hedayati S, Minhajuddin A, Toto R, Morris D, Rush A,. Prevalence of major depressive episode in CKD. Am. J. Kidney Dis. 2009; 54: 424-432.
16. Hedayati S, Jiang W, O'Connor C, et al. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. Am. J. Kidney Dis. 2004; 44: 207-215.
17. Tsai Y-C, Chiu Y-W, Hung C-C, et al. Association of symptoms of depression with progression of CKD. Am. J. Kidney Dis. 2012; 60: 54-61.
18. Tsai Y-C, Hung C-C, Hwang S-J, et al. Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol. Dial. Transpl. 2010; 25: 1621-1626.
19. Ng CG, Boks MPM, Zainal NZ, De Wit NJ,. The prevalence and pharmacotherapy of depression in cancer patients. J. Affect. Disorders 2011; 131: 1-7.
20. Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: A meta-analysis of cohort studies. Am. J. Kidney Dis. 2013; doi: http://dx.doi.org/ 10.1053/j.ajkd.2013.02.369.
21. Hedayati S, Minhajuddin A, Afshar M, Toto R, Trivedi M, Rush A,. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 2010; 303: 1946-1953.
22. Kellerman Q, Christensen A, Baldwin A, Lawton W,. Association between depressive symptoms and mortality risk in chronic kidney disease. Health Psychol. 2010; 29: 594-600.
23. Fischer MJ, Kimmel PL, Greene T, et al. Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int. 2011; 80: 670-678.
24. Cukor D, Coplan J, Brown C, et al. Anxiety disorders in adults treated by hemodialysis: A single-center study. Am. J. Kidney Dis. 2008; 52: 128-136.
25. McKercher C, Venn A, Blizzard L, et al. Psychosocial factors in adults with chronic kidney disease: Characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study. BMC Nephrol. 2013; 14: 83.
26. Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of Results 2007. Canberra: ABS, 2008.
27. Lee Y, Kim M, Cho S, Kim S,. Association of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney disease. Int. J. Clin. Pract. 2013; 67: 363-368.
28. Uchino B,. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. J. Behav. Med. 2006; 29: 377-387.
29. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998; 54: 245-254.
30. Porter A, Fischer M, Brooks D, et al. Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl. Res. 2012; 159: 4-11.
31. George LK, Larson DB, Koenig HG, McCullough ME,. Spirituality and health: What we know, what we need to know. J. Soc. Clin. Psychol. 2000; 19: 102-116.
32. Lucchetti G, Almeida L, Granero A,. Spirituality for dialysis patients: Should the nephrologist address? J. Bras. Doencas Torac. 2010; 32: 126-130.
33. Davison S, Jhangri G,. The relationship between spirituality, psychosocial adjustment to illness, and health-related quality of life in patients with advanced chronic kidney disease. J. Pain. Symptom. Manag. 2013; 45: 170-178.
34. Spinale J, Cohen S, Khetpal P, et al. Spirituality, social support, and survival in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2008; 3: 1620-1627.
35. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual. Life Res. 2000; 9: 887-900.
36. Finkelstein FO, Wuerth D, Finkelstein SH,. Health related quality of life and the CKD patient: Challenges for the nephrology community. Kidney Int. 2009; 76: 946-952.
37. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am. J. Kidney Dis. 2005; 45: 658-666.
38. Alvarez-Ude Cotera F, Rebollo Alvarez P,. Psychological disturbances and deterioration of health-related quality of life of patients with stage 3-5 chronic kidney disease (not on dialysis). Nefrología 2008; 28 (Suppl 3): 57-62.
39. Spiegel BM, Melmed G, Robbins S, Esrailian E,. Biomarkers and health-related quality of life in end-stage renal disease: A systematic review. Clin. J. Am. Soc. Nephrol. 2008; 3: 1759-1768.
40. Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: Correlates and evolution over time. Clin. J. Am. Soc. Nephrol. 2009; 4: 1293-1301.
41. Albus C,. Psychological and social factors in coronary heart disease. Ann. Med. 2010; 42: 487-494.
42. Schneiderman N, Ironson G, Siegel SD,. Stress and health: Psychological, behavioral, and biological determinants. Annu. Rev. Clin. Psychol. 2005; 1: 607-628.
43. Simic Ogrizovic S, Jovanovic D, Dopsaj V, et al. Could depression be a new branch of MIA syndrome? Clin. Nephrol. 2009; 71: 164-172.
44. Serebruany V,. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: Evidence from recent clinical trials. Blood Coagul. Fibrinolysis 2003; 14: 563-567.
45. Gans RO,. The metabolic syndrome, depression, and cardiovascular disease: Interrelated conditions that share pathophysiologic mechanisms. Med. Clin. North Am. 2006; 90: 573-591.
46. Lloyd B,. Qualitative Study Investigating How Tasmanian Healthcare Providers and People with Chronic Kidney Disease and Low Kidney Function View Dialysis [Masters Thesis]. Hobart: University of Tasmania, 2011.
47. Fekete E, Antoni M, Schneiderman N,. Psychosocial and behavioral interventions for chronic medical conditions. Curr. Opin. Psychiatry 2007; 20: 152-157.
48. Leverone D, Epstein B,. Nonpharmacological interventions for the treatment of rheumatoid arthritis: A focus on mind-body medicine. J. Pharm. Pharmacol. 2010; 23: 101-109.
49. Hedayati S, Yalamanchili V, Finkelstein F,. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012; 81: 247-255.
50. Kao Y, Huang Y, Chen P, Wang K,. The effects of exercise education intervention on the exercise behaviour, depression, and fatigue status of chronic kidney disease patients. Health Educ. 2012; 112: 472-484.
51. Johnson DW, Atai E, Chan M, et al. KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management. Nephrology 2013; 18: 340-350.
52. Weeks A, McAvoy B, Peterson C, et al. Negotiating ownership of chronic illness: An appropriate role for health professionals in chronic illness self-management programs. Aust. J. Prim. Health 2003; 9: 25-33.
53. Levin A, Lewis M, Mortiboy P, et al. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am. J. Kidney Dis. 1997; 29: 533-540.
54. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L,. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J. Am. Coll. Cardiol. 2005; 45: 637-651.